The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment
Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in […]
Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic.
At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most […]
A growing number of patients are considering clinical trials as the coronavirus pandemic continues.
In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout […]
Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic.
The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, […]
Drastic Attrition in Digital Clinical Trials Points to New Issues with Patient Engagement
Digital clinical trials are dramatically boosting patient enrollment – now it’s time for sponsors and CROs to focus on retention.
Report: Receiving Clinical Trial Results Makes Patients More Likely to Participate
A recent study reveals that sharing clinical trial results with patients can help boost trial participation and engagement.
Are ‘Professional Patients’ in Clinical Trials an Epidemic?
So-called “professional patients” threaten the integrity of clinical trials, but can they be stopped?
Choosing the Right Investigator Sites is Key to Patient Recruitment
A successful clinical trial begins with choosing the right investigator sites. Here’s what to consider when selecting sites – and how digital marketing can help.
FDA Leading the Charge to Recruit More Female Patients to Clinical Trials
FDA Commissioner Scott Gottlieb recently expressed the agency’s commitment to women’s health initiatives. Here’s what that means for sponsors and CROs looking to recruit women for clinical trials.
